Vitamin D Deficiency and Vascular Lesions in Diabetes Mellitus Type 2
Journal Title: Міжнародний ендокринологічний журнал - Year 2013, Vol 5, Issue 53
Abstract
Background. For today low level of vitamin D in the blood serum in patients with diabetes mellitus (DM) type 2 is considered as a prognostic index of further development of macrovascular lesions, herewith connection of vitamin D deficiency with capillary complications is studied not enough. The objective of the study — to establish provision of the organism of patients with DM type 2 with vitamin D, and also the correlation of vitamin D deficiency with macro- and microvascular diabetic complications. Materials and methods of study: 44 patients with type 2 DM were under observation. Examination of vitamin D level (Vit. D total) and parathyroid hormone of blood serum was carried out using chemiluminescent method on Elecsys 2010 analyzer (Roche Diagnostics, Germany) with cobas test systems. Results: in all patients with type 2 DM we have detected vitamin D deficiency (mean value of 20.29 ± 1.35 nM/L), changes in parathyroid hormone content were not revealed. We noted significantly lower levels of vitamin D sufficiency of the body in patients with proliferative diabetic retinopathy compared with patients who did not reveal diabetic retinopathy. Conclusions: all patients who suffer from type 2 DM revealed vitamin D deficiency, and 80 % of them had severe deficiency. A trend towards higher incidence of macrovascular lesions of the lower extremities in vitamin D deficiency has been detected. Vitamin D deficiency contributes to DM decompensation and as a consequence, the worsening of vascular lesions of the retina.
Authors and Affiliations
A. S. Yefimov, L. M. Mikhalchuk
Keywords
Related Articles
- EP ID EP233114
- DOI -
- Views 31
- Downloads 0
Assessment of Glycemia Impact on the Parameters of Sleep in Type 1 Diabetes Mellitus: the Results of Cross-Sectional Cohort Trial
This study demonstrates the impact of glycemia according to daily monitoring of blood glucose on parameters of nocturnal sleep in type 1 diabetic patients, regardless of the glycated haemoglobin level.
Influence of VEGFA gene polymorphisms rs2010963 and rs699947 on clinical and laboratory indicators in diabetic retinopathy among patients with type 2 diabetes mellitus
Background. A key factor of neoangiogenesis development in diabetic retinopathy (DR) among patients with type 2 diabetes mellitus (DM) is vascular endothelial growth factor A (VEGFA). The important role of genetic polym...
Dynamics of thyroid gland sizes in patients with diffuse and nodular goiter, autoimmune thyroiditis during monotherapy by Alba® preparation in different regions of Ukraine
Background. The purpose of work was to evaluate the dynamics of thyroid volume in patients with autoimmune thyroiditis (АТ), diffuse non-toxic goiter (DNG) and nodular goiter (NG) during monotherapy by herbal preparation...
The rs1800629 polymorphism of the TNFα gene in type 2 diabetes mellitus: association with nephropathy
Background. In diabetes mellitus (DM), endothelial dysfunction (EDF) is formed that determines the rate and severity of the disease complications. Among other factors, there is the presence of genetic polymorphism, which...
Screening for Type 2 Diabetes Mellitus by Determination of Glycated Hаemoglobin
Objective — to identify the prevalence of disorders of carbohydrate metabolism according to the results of for glycated hemoglobin screening. Materials and Methods. The determination of glycated hemoglobin (HbA1c) in 156...